Daratumumab, Venetoclax, and Azacitidine in Combination with HAA Regimen as Consolidation Chemotherapy for T-cell Acute Lymphoblastic Leukemia with High CD38 Expression

Feng LS, Li HY, Tang A, Xu ML, Wang SB
У данной статьи нет абстракта.
Turkish journal of haematology : official journal of Turkish Society of Haematology, 2025-05-08